Smart pills are small embedded electronic devices, which include sensors, cameras, patches and trackers. These pills are capable of providing complete diagnostic evaluation of the gastrointestinal tract when swallowed. There are several advantages of smart pills such as it enables noninvasive diagnosis of diseases, and patient adherence and satisfaction.
Major factors hampering the growth of the ingestible smart pills market during the forecast period constitutes of limited studies on efficacy comparison of treating agents, and challenging manufacturing process.
- This report provides in-depth analysis of the global ingestible smart pills market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026–2033), considering 2025, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global ingestible smart pills market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include BodyCap Medical, Given Imaging Ltd., Olympus Corporation, Proteus Digital Health, Inc., CapsoVision, Inc., Chongqing Jinshan Science and Component (Group) Co., Ltd., Medimetrics, IntroMedic Co., Ltd., Check-Cap Ltd., Boston Scientific Corporation, HQ Inc., Smart Pill Inc., Medtronic plc, Philips Healthcare, etectRx, Inc., Novartis, Siemens Healthcare, Pentax Medical Company (HOYA Corporation), GE Healthcare, and Stryker Corporation.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global ingestible smart pills market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
-
- Smart Pills
- Patient Monitoring
- Capsule Endoscopy
- Small Bowel Endoscopy
- Esophagus Endoscopy
- Colon Endoscopy
- Workstation
-
-
- Hospitals
- Clinics
- Research Institutes
- Home Healthcare
-
- North America
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
-
- BodyCap Medical
- Given Imaging Ltd.
- Olympus Corporation
- Proteus Digital Health, Inc.
- CapsoVision, Inc.
- Chongqing Jinshan Science and Component (Group) Co., Ltd.
- Medimetrics
- IntroMedic Co., Ltd.
- Check-Cap Ltd.
- Boston Scientific Corporation
- HQ Inc.
- Smart Pill Inc.
- Medtronic plc
- Philips Healthcare
- etectRx, Inc.
- Novartis
- Siemens Healthcare
- Pentax Medical Company (HOYA Corporation)
- GE Healthcare
- Stryker Corporation
